Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
about
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancerRole of systemic chemotherapy in urothelial urinary bladder cancerMDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy.Optimal timing of chemotherapy and cystectomy.Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC)Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy.Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review.Progress in personalizing chemotherapy for bladder cancerTreatment of locally advanced and metastatic bladder cancerPerioperative chemotherapy for muscle-invasive bladder cancer.NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods?Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen.Neoadjuvant chemotherapy for invasive bladder cancer.Oncologic outcomes obtained after neoadjuvant and adjuvant chemotherapy for the treatment of urothelial carcinomas of the upper urinary tract: a review.Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.Perioperative chemotherapy: the case for adjuvant chemotherapy for muscle-invasive bladder cancer.What is the role of adjuvant chemotherapy in locally advanced and lymph node-positive bladder cancer after radical cystectomy?Systemic Therapy for Invasive Bladder Cancer: The Value Proposition.Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting.Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials.Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].Update on chemotherapy in the treatment of urothelial carcinoma
P2860
Q26773664-0409EAA4-922F-4A37-B206-C76828FC2C2FQ27010323-35DECD29-4039-4DC7-8988-BE859581EA9DQ33651005-08E773ED-CFA9-42A2-9453-FF022B931488Q34175543-3E3147BD-8BC3-4651-9F48-240F18683605Q34337059-F7C4AF82-7F15-46BB-81B7-AD4034735B51Q34816825-5E327019-D0AC-46F9-A635-9E1DDBC32F7BQ34993621-E98B6794-DE03-43A2-B541-0875FD4DCBD6Q35779460-F23A1BC9-BFFA-4D13-AF2D-EF3676B92E00Q37197514-4BE824C5-0DBE-4E6A-B21A-CEA15CCCA840Q37472550-B653D320-ECB2-4B66-8B34-6A2FCD4159D9Q37736774-1A6C924B-BD1D-49BC-89F9-DC253C335CF2Q37906784-65AC2292-6CDC-4991-9B4A-143213371872Q37955283-A3133803-FA9A-4887-ACC0-66B403225A11Q37982318-C29C1AC6-56BD-469D-8F85-4798A5383EE4Q38051010-9A7FA544-5DF8-4150-993B-849E81186F71Q38218163-49144692-9550-4167-9806-D17D47E20650Q39855461-6ED2A8B8-933A-43EF-8DBC-53FA8F26D029Q41264196-B743F18D-F259-43D1-BC0D-AEA74C6F33A5Q42039017-4A5F11C2-E024-414E-BD06-07D9F9102D6DQ42079380-771FD9C4-8E16-47F0-947C-D9AAB1377C7CQ43196454-A1772592-6EB0-41E9-B97C-9A7B69FCD03CQ44789122-43B67952-AFD2-4EFF-8A75-E3923175F7D2Q46613374-836E99DE-3619-4ADF-8406-C4279C8FDA35Q47137922-CADC9783-1D1A-4F61-8E91-2CF068352183Q49526759-10CE2576-66C3-4D6D-957C-3FD0A2366596Q53462584-F34FBF3A-B26A-49CD-AFFC-F85BB9DB5BD7Q58694390-47A1B952-3769-4C06-9B72-E4DDC47CE5BA
P2860
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Complete long-term survival da ...... cally advanced bladder cancer.
@ast
Complete long-term survival da ...... cally advanced bladder cancer.
@en
type
label
Complete long-term survival da ...... cally advanced bladder cancer.
@ast
Complete long-term survival da ...... cally advanced bladder cancer.
@en
prefLabel
Complete long-term survival da ...... cally advanced bladder cancer.
@ast
Complete long-term survival da ...... cally advanced bladder cancer.
@en
P2093
P2860
P1433
P1476
Complete long-term survival da ...... cally advanced bladder cancer.
@en
P2093
Jan Lehmann
Joachim Thüroff
Ludger Franzaring
Michael Stöckle
Stefan Wellek
P2860
P356
10.1111/J.1464-410X.2006.05859.X
P577
2006-01-01T00:00:00Z